Nomura Holdings Inc. acquired a new stake in ChampionX Co. (NASDAQ:CHX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 25,230 shares of the company's stock, valued at approximately $686,000.
Several other large investors have also made changes to their positions in the business. Barclays PLC grew its holdings in ChampionX by 147.2% during the third quarter. Barclays PLC now owns 357,081 shares of the company's stock worth $10,766,000 after acquiring an additional 212,654 shares during the period. Park Avenue Securities LLC lifted its holdings in ChampionX by 7.6% in the fourth quarter. Park Avenue Securities LLC now owns 28,846 shares of the company's stock valued at $784,000 after acquiring an additional 2,031 shares during the period. Nisa Investment Advisors LLC boosted its position in ChampionX by 899.3% in the 4th quarter. Nisa Investment Advisors LLC now owns 211,103 shares of the company's stock worth $5,740,000 after purchasing an additional 189,977 shares in the last quarter. KBC Group NV grew its stake in shares of ChampionX by 42.3% during the 4th quarter. KBC Group NV now owns 8,289 shares of the company's stock worth $225,000 after purchasing an additional 2,462 shares during the period. Finally, Pacer Advisors Inc. grew its stake in shares of ChampionX by 1.9% during the 4th quarter. Pacer Advisors Inc. now owns 28,394 shares of the company's stock worth $772,000 after purchasing an additional 532 shares during the period. 98.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Separately, Stifel Nicolaus boosted their target price on shares of ChampionX from $39.00 to $40.00 and gave the company a "buy" rating in a research note on Monday, May 5th.
Check Out Our Latest Report on CHX
ChampionX Price Performance
Shares of ChampionX stock traded down $0.02 on Monday, hitting $24.48. The company's stock had a trading volume of 3,558,468 shares, compared to its average volume of 2,712,307. The company has a market capitalization of $4.69 billion, a price-to-earnings ratio of 14.84 and a beta of 1.52. The firm has a fifty day moving average price of $25.97 and a 200-day moving average price of $28.03. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.36 and a current ratio of 1.99. ChampionX Co. has a 1 year low of $21.92 and a 1 year high of $35.94.
ChampionX (NASDAQ:CHX - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.50 EPS for the quarter, beating analysts' consensus estimates of $0.41 by $0.09. ChampionX had a return on equity of 19.84% and a net margin of 8.81%. The business had revenue of $864.46 million during the quarter, compared to analysts' expectations of $900.59 million. During the same period in the previous year, the business earned $0.50 earnings per share. The business's revenue was down 6.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that ChampionX Co. will post 1.92 earnings per share for the current fiscal year.
ChampionX Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Thursday, July 3rd will be given a dividend of $0.095 per share. This represents a $0.38 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Thursday, July 3rd. ChampionX's dividend payout ratio is presently 25.17%.
About ChampionX
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Featured Articles

Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.